Orient Pharma Co., Ltd. (4166.TWO)

TWD 37.1

(-2.5%)

Net Debt Summary of Orient Pharma Co., Ltd.

  • Orient Pharma Co., Ltd.'s latest annual net debt in 2023 was 633.6 Million TWD , up 46.74% from previous year.
  • Orient Pharma Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 287.43 Million TWD , up 3.91% from previous quarter.
  • Orient Pharma Co., Ltd. reported annual net debt of 431.77 Million TWD in 2022, up 51.82% from previous year.
  • Orient Pharma Co., Ltd. reported annual net debt of 284.41 Million TWD in 2021, up 3.63% from previous year.
  • Orient Pharma Co., Ltd. reported quarterly net debt of 287.43 Million TWD for 2024 Q2, up 3.91% from previous quarter.
  • Orient Pharma Co., Ltd. reported quarterly net debt of 639.69 Million TWD for 2023 Q2, up 2.89% from previous quarter.

Annual Net Debt Chart of Orient Pharma Co., Ltd. (2023 - 2019)

Historical Annual Net Debt of Orient Pharma Co., Ltd. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 633.6 Million TWD 46.74%
2022 431.77 Million TWD 51.82%
2021 284.41 Million TWD 3.63%
2020 274.45 Million TWD -14.68%
2019 321.68 Million TWD 0.0%

Peer Net Debt Comparison of Orient Pharma Co., Ltd.

Name Net Debt Net Debt Difference
Allied Biotech Corporation 178.11 Million TWD -255.734%
GeneFerm Biotechnology Co., Ltd. 31.92 Million TWD -1884.614%
Easywell Biomedicals, Inc. 123.43 Million TWD -413.305%
TTY Biopharm Company Limited -705.97 Million TWD 189.749%
Synmosa Biopharma Corporation 1.52 Billion TWD 58.351%
Orient EuroPharma Co., Ltd. 3.1 Billion TWD 79.603%
Center Laboratories, Inc. 3.91 Billion TWD 83.833%
Tien Liang BioTech Co., Ltd. -57.55 Million TWD 1200.855%
InnoPharmax Inc. -17.85 Million TWD 3648.034%
Johnson Chemical Pharmaceutical Works Co., Ltd. -926.77 Million TWD 168.367%
Excelsior Biopharma Inc. -212.51 Million TWD 398.15%
DV Biomed Co., Ltd. 160.7 Million TWD -294.28%
Foresee Pharmaceuticals Co., Ltd. -781.42 Million TWD 181.084%
Handa Pharmaceuticals, Inc. -653.8 Million TWD 196.911%
UniPharma Co., Ltd. -68.36 Million TWD 1026.775%
Anxo Pharmaceutical Co., Ltd. 492.4 Million TWD -28.676%
Alar Pharmaceuticals Inc. -738.05 Million TWD 185.848%
Winston Medical Supply Co., Ltd. -191.81 Million TWD 430.331%
Mercury Biopharmaceutical Corporation -1.94 Million TWD 32676.247%
Bioray Biotech Co., Ltd -27.23 Million TWD 2426.704%
TSH Biopharm Corporation Limited -568.74 Million TWD 211.405%